We currently have an expert advisory committee on the vigilance of health products, which has just been struck a few months ago, which includes patient-consumer groups and health care professionals. They're there to provide advice to me in terms of post-market surveillance issues related to health products. This is a new expert advisory committee.
On January 31st, 2008. See this statement in context.